Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $75 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Pfizer (NYSE:PFE) and maintained a $75 price target on the stock.
November 20, 2023 | 5:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen maintains an Overweight rating on Pfizer with a $75 price target, indicating a positive outlook on the stock.
The reiteration of an Overweight rating and the maintenance of a $75 price target by a reputable analyst could lead to increased investor confidence in Pfizer, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100